Literature DB >> 20595630

Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice.

Manuel Buttini1, Eliezer Masliah, Gui-Qiu Yu, Jorge J Palop, Shengjun Chang, Aubrey Bernardo, Carol Lin, Tony Wyss-Coray, Yadong Huang, Lennart Mucke.   

Abstract

The lipid transport protein apolipoprotein E (apoE) is abundantly expressed in the brain. Its main isoforms in humans are apoE2, apoE3, and apoE4. ApoE4 is the major known genetic risk factor for Alzheimer's disease and also contributes to the pathogenesis of various other neurological conditions. In the central nervous system, apoE is synthesized by glial cells and neurons, but it is unclear whether the cellular source affects its biological activities. To address this issue, we induced excitotoxic injury by systemic kainic acid injection in transgenic Apoe knockout mice expressing human apoE isoforms in astrocytes or neurons. Regardless of its cellular source, apoE3 expression protected neuronal synapses and dendrites against the excitotoxicity seen in apoE-deficient mice. Astrocyte-derived apoE4, which has previously been shown to have detrimental effects in vitro, was as excitoprotective as apoE3 in vivo. In contrast, neuronal expression of apoE4 was not protective and resulted in loss of cortical neurons after excitotoxic challenge, indicating that neuronal apoE4 promotes excitotoxic cell death. Thus, an imbalance between astrocytic (excitoprotective) and neuronal (neurotoxic) apoE4 expression may increase susceptibility to diverse neurological diseases involving excitotoxic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595630      PMCID: PMC2913361          DOI: 10.2353/ajpath.2010.090973

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

Review 1.  Excitotoxicity and the NMDA receptor--still lethal after eight years.

Authors:  S M Rothman; J W Olney
Journal:  Trends Neurosci       Date:  1995-02       Impact factor: 13.837

2.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.

Authors:  D M Holtzman; K R Bales; T Tenkova; A M Fagan; M Parsadanian; L J Sartorius; B Mackey; J Olney; D McKeel; D Wozniak; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Apolipoprotein E expression by neurons surviving excitotoxic stress.

Authors:  U Boschert; E Merlo-Pich; G Higgins; A D Roses; S Catsicas
Journal:  Neurobiol Dis       Date:  1999-12       Impact factor: 5.996

4.  Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

5.  Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).

Authors:  B T Hyman; H L West; G W Rebeck; S V Buldyrev; R N Mantegna; M Ukleja; S Havlin; H E Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

6.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

Authors:  D E Schmechel; A M Saunders; W J Strittmatter; B J Crain; C M Hulette; S H Joo; M A Pericak-Vance; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

Review 7.  Excitatory transmitter neurotoxicity.

Authors:  J W Olney
Journal:  Neurobiol Aging       Date:  1994 Mar-Apr       Impact factor: 4.673

8.  Human apolipoprotein E isoprotein subclasses are genetically determined.

Authors:  V I Zannis; P W Just; J L Breslow
Journal:  Am J Hum Genet       Date:  1981-01       Impact factor: 11.025

Review 9.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.

Authors:  Guojun Bu
Journal:  Nat Rev Neurosci       Date:  2009-04-02       Impact factor: 34.870

10.  Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease.

Authors:  Alan H Nagahara; David A Merrill; Giovanni Coppola; Shingo Tsukada; Brock E Schroeder; Gideon M Shaked; Ling Wang; Armin Blesch; Albert Kim; James M Conner; Edward Rockenstein; Moses V Chao; Edward H Koo; Daniel Geschwind; Eliezer Masliah; Andrea A Chiba; Mark H Tuszynski
Journal:  Nat Med       Date:  2009-02-08       Impact factor: 53.440

View more
  34 in total

Review 1.  Mouse models of Alzheimer's disease.

Authors:  Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2011-11-28       Impact factor: 4.077

2.  C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice.

Authors:  Nga Bien-Ly; Yaisa Andrews-Zwilling; Qin Xu; Aubrey Bernardo; Charles Wang; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

Review 3.  Alzheimer mechanisms and therapeutic strategies.

Authors:  Yadong Huang; Lennart Mucke
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 4.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.

Authors:  Chia-Chen Liu; Chia-Chan Liu; Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2013-01-08       Impact factor: 42.937

Review 5.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

6.  Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice.

Authors:  Johanna Knoferle; Seo Yeon Yoon; David Walker; Laura Leung; Anna K Gillespie; Leslie M Tong; Nga Bien-Ly; Yadong Huang
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

Review 7.  Cell-specific production, secretion, and function of apolipoprotein E.

Authors:  Maaike Kockx; Mathew Traini; Leonard Kritharides
Journal:  J Mol Med (Berl)       Date:  2018-03-07       Impact factor: 4.599

Review 8.  The dendritic hypothesis for Alzheimer's disease pathophysiology.

Authors:  J Nicholas Cochran; Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2013-12-12       Impact factor: 4.077

9.  Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors.

Authors:  Jens Brodbeck; Jim McGuire; Zhaoping Liu; Anke Meyer-Franke; Maureen E Balestra; Dah-eun Jeong; Mike Pleiss; Casey McComas; Fred Hess; David Witter; Scott Peterson; Matthew Childers; Mark Goulet; Nigel Liverton; Richard Hargreaves; Stephen Freedman; Karl H Weisgraber; Robert W Mahley; Yadong Huang
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

Review 10.  The basis of cellular and regional vulnerability in Alzheimer's disease.

Authors:  Dunja Mrdjen; Edward J Fox; Syed A Bukhari; Kathleen S Montine; Sean C Bendall; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2019-08-07       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.